EUVIMEDScopri EUVIMED
Crossref

Triptolide injection reduces Alzheimer's disease‐like pathology in mice

Rui Mao, Shihao Xu, Guangwen Sun, Yingying Yu, Zhiyi Zuo, Yuanyuan Wang, Kun Yang, Zhen Zhang, Wenqiong Yang

Synapse · 2023

DOI: 10.1002/syn.22261 ↗

At a glance

Journal article in Synapse, 2023. Written by Rui Mao and 8 co-authors. Institution: Department of Neurology, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, China. Major MEDLINE topics: Alzheimer Disease, Diterpenes. Cited 8 times so far (Crossref); 42 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Triptolide is an epoxidized diterpene lactone isolated from Tripterygium wilfordii . Studies have shown that triptolide exerts organ‐protective effects. However, it remains unknown whether triptolide improves Alzheimer's disease (AD)‐like presentations. Thirty healthy 8‐week‐old male C57BL/6J mice were randomly divided into control ( n = 10), model ( n = 10), and triptolide ( n = 10) groups. Amyloid‐β (Aβ)42 was injected bilaterally into the ventricles of mice in the model group. Triptolide was injected intraperitoneally daily after injecting Aβ42 (a total of 30 days) in the triptolide group. Learning and memory were tested using the Morris water maze test. The deposition of Aβ42 in the hippocampus was detected using immunohistochemical staining. In the hippocampus, three synaptic‐associated proteins—gephyrin, collybistin, and GABRA 1 —were detected by western blotting. Furthermore, we used ELISA to detect proinflammatory cytokines, including TNF‐α and IL‐1β, in the blood and hippocampus. Moreover, superoxide dismutase (SOD), malondialdehyde (MDA), and GSH levels were measured using the corresponding kits. We found that triptolide improved spatial learning and memory in AD‐like mice. Additionally, triptolide maintained the expression of gephyrin, collybistin, and GABRA 1 and reduced Aβ in these mice. Additionally, triptolide reduced the expression of inflammatory cytokines and decreased oxidative damage in AD‐like mice. Our study suggests that triptolide attenuates AD‐like changes in the mouse brain.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseDiterpenesMiceMaleAnimalsMice, Inbred C57BLAmyloid beta-PeptidesHippocampusCytokinesDisease Models, AnimalEpoxy CompoundsPhenanthrenes

Author keywords

Alzheimer's diseaseGABAARcollybistingephyrininflammationoxidative stresspostsynaptic structuretriptolide

Substances

Amyloid beta-PeptidesDiterpenesCytokinestriptolideEpoxy CompoundsPhenanthrenes

Authors and institutions

  • Department of Neurology, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
  • Department of Neurology, Sinopharm Dongfeng General Hospital, Jinzhou Medical University Union Training Base, Jinzhou, China.
  • Department of Anesthesiology, University of Virginia School of Medicine, Charlottesville, Virginia.
  • Department of Anesthesiology, Sinopharm Dongfeng General Hospital, Jinzhou Medical University Union Training Base, Jinzhou, China.
  • Department of Orthopedics, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, China.

Cite

APA

Mao, R., Xu, S., Sun, G., Yu, Y., Zuo, Z., Wang, Y., Yang, K., Zhang, Z., & Yang, W. (2023). Triptolide injection reduces Alzheimer's disease‐like pathology in mice. Synapse. https://doi.org/10.1002/syn.22261

Vancouver

Mao R, Xu S, Sun G, Yu Y, Zuo Z, Wang Y, et al. Triptolide injection reduces Alzheimer's disease‐like pathology in mice. Synapse. 2023. doi:10.1002/syn.22261

BibTeX
@article{Mao2023,
  author = {Mao, Rui and Xu, Shihao and Sun, Guangwen and Yu, Yingying and Zuo, Zhiyi and Wang, Yuanyuan and Yang, Kun and Zhang, Zhen and Yang, Wenqiong},
  title = {Triptolide injection reduces Alzheimer's disease‐like pathology in mice},
  journal = {Synapse},
  year = {2023},
  doi = {10.1002/syn.22261}
}
Start for free →